Hasil Pencarian - Zoltan Kalo

Perbaiki Hasil
  1. 1
    How Changes in Reimbursement Practices Influence the Financial Sustainability of Medicine Policy: Lessons Learned from Slovakia

    How Changes in Reimbursement Practices Influence the Financial Sustainability of Medicine Policy: Lessons Learned from Slovakia oleh Tomas Tesar, Branislav Obsitnik, Zoltán Kaló, Zoltán Kaló, Finn Børlum Kristensen

    Diterbitkan 2019-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Assessing the Consequences of External Reference Pricing for Global Access to Medicines and Innovation: Economic Analysis and Policy Implications

    Assessing the Consequences of External Reference Pricing for Global Access to Medicines and Innovation: Economic Analysis and Policy Implications oleh András Incze, András Incze, Zoltán Kaló, Zoltán Kaló, Jaime Espín, Éva Kiss, Sophia Kessabi, Louis P. Garrison

    Diterbitkan 2022-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Cost-Utility Analysis of Heberprot-P as an Add-on Therapy to Good Wound Care for Patients in Slovakia with Advanced Diabetic Foot Ulcer

    Cost-Utility Analysis of Heberprot-P as an Add-on Therapy to Good Wound Care for Patients in Slovakia with Advanced Diabetic Foot Ulcer oleh Tomas Tesar, Laszlo Szilberhorn, Laszlo Szilberhorn, Bertalan Nemeth, Balazs Nagy, Balazs Nagy, Martin Wawruch, Zoltan Kalo, Zoltan Kalo

    Diterbitkan 2017-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Potential Criteria for Frameworks to Support the Evaluation of Innovative Medicines in Upper Middle-Income Countries—A Systematic Literature Review on Value Frameworks and Multi-Criteria Decision Analyses

    Potential Criteria for Frameworks to Support the Evaluation of Innovative Medicines in Upper Middle-Income Countries—A Systematic Literature Review on Value Frameworks and Multi-Cr... oleh Ivett Jakab, Bertalan Németh, Baher Elezbawy, Melis Almula Karadayı, Hakan Tozan, Sabahattin Aydın, Jie Shen, Zoltán Kaló, Zoltán Kaló

    Diterbitkan 2020-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    Patient and Payer Preferences for Additional Value Criteria

    Patient and Payer Preferences for Additional Value Criteria oleh Ivett Jakab, Melanie D. Whittington, Elizabeth Franklin, Susan Raiola, Jonathan D. Campbell, Zoltán Kaló, Zoltán Kaló, R. Brett McQueen

    Diterbitkan 2021-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    Barriers to Use Artificial Intelligence Methodologies in Health Technology Assessment in Central and East European Countries

    Barriers to Use Artificial Intelligence Methodologies in Health Technology Assessment in Central and East European Countries oleh Konstantin Tachkov, Antal Zemplenyi, Antal Zemplenyi, Maria Kamusheva, Maria Dimitrova, Pekka Siirtola, Johan Pontén, Bertalan Nemeth, Zoltan Kalo, Zoltan Kalo, Guenka Petrova

    Diterbitkan 2022-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    Incremental cost of premature birth – a public health care payer perspective from Hungary

    Incremental cost of premature birth – a public health care payer perspective from Hungary oleh Gábor Kovács, Zsolt Abonyi-Tóth, Petra Fadgyas-Freyler, Zoltán Kaló

    Diterbitkan 2023-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  8. 8
    Overview on Patient Centricity in Cancer Care

    Overview on Patient Centricity in Cancer Care oleh Šarunas Narbutas, Šarunas Narbutas, Kristina York, Barry D. Stein, Kara Magsanoc-Alikpala, Yoshiyuki Majima, Zoltan Kalo, Zoltan Kalo, Timea Almasi, Andras Inotai, Andras Inotai

    Diterbitkan 2017-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  9. 9
    Revealed preferences towards the appraisal of orphan drugs in Poland - multi criteria decision analysis

    Revealed preferences towards the appraisal of orphan drugs in Poland - multi criteria decision analysis oleh Katarzyna Kolasa, Krzysztof Miroslaw Zwolinski, Vladimir Zah, Zoltán Kaló, Tadeusz Lewandowski

    Diterbitkan 2018-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  10. 10
    Identifying Patient Access Barriers for Tumor Necrosis Factor Alpha Inhibitor Treatments in Rheumatoid Arthritis in Five Central Eastern European Countries

    Identifying Patient Access Barriers for Tumor Necrosis Factor Alpha Inhibitor Treatments in Rheumatoid Arthritis in Five Central Eastern European Countries oleh András Inotai, András Inotai, Dominik Tomek, Maciej Niewada, Maciej Niewada, László Lorenzovici, László Lorenzovici, Martin Kolek, Jakub Weber, Anne-Katrin Kurrat, Emese Virág Kiss, Zoltán Kaló, Zoltán Kaló

    Diterbitkan 2020-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  11. 11
    Recommendation for a Pilot MCDA Tool to Support the Value-Based Purchasing of Generic Medicines in the UAE

    Recommendation for a Pilot MCDA Tool to Support the Value-Based Purchasing of Generic Medicines in the UAE oleh Mohamed Naser Farghaly, Sara Ahmad Mohammad Al Dallal, Ahmad Nader Fasseeh, Ahmad Nader Fasseeh, Nahed AbdulKhaleq Monsef, Eldaw Abdalla Mohamed Ali Suliman, Mohamed Attia Tahoun, Sherif Abaza, Zoltán Kaló, Zoltán Kaló

    Diterbitkan 2021-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  12. 12
    Is there a fair allocation of healthcare research funds by the European Union?

    Is there a fair allocation of healthcare research funds by the European Union? oleh Zoltán Kaló, Loek Hendrik Matheo van den Akker, Zoltán Vokó, Marcell Csanádi, János György Pitter

    Diterbitkan 2019-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  13. 13
    Patient access to reimbursed biological disease-modifying antirheumatic drugs in the European region

    Patient access to reimbursed biological disease-modifying antirheumatic drugs in the European region oleh Zoltán Kaló, Zoltán Vokó, Andrew Östör, Emma Clifton-Brown, Radu Vasilescu, Alysia Battersby, Edward Gibson

    Diterbitkan 2017-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  14. 14
    Stakeholder driven development of a multi-criteria decision analysis tool for purchasing off-patent pharmaceuticals in Kuwait

    Stakeholder driven development of a multi-criteria decision analysis tool for purchasing off-patent pharmaceuticals in Kuwait oleh Ali Hadi Abdullah, Anke-Peggy Holtorf, Maryam Al-Hussaini, Jacinthe Lemay, Maryam Alowayesh, Zoltán Kaló

    Diterbitkan 2019-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  15. 15
    A concept for multi-winner tenders for medicinal products with balancing between efficient prices, long-term competition and sustainability of supply

    A concept for multi-winner tenders for medicinal products with balancing between efficient prices, long-term competition and sustainability of supply oleh Gergely Németh, Gergely Németh, Mánuel László Mágó, Zoltán Kaló, Judit Lám, Tamás Balogh, Valentin Brodszky

    Diterbitkan 2023-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  16. 16
    Facilitators and Barriers of Incremental Innovation by Fixed Dose Combinations in Cardiovascular Diseases

    Facilitators and Barriers of Incremental Innovation by Fixed Dose Combinations in Cardiovascular Diseases oleh András Inotai, Zoltán Kaló, Zsuzsanna Petykó, Kristóf Gyöngyösi, Derek T. O’Keeffe, Marcin Czech, Tamás Ágh

    Diterbitkan 2024-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  17. 17
    Delayed payment schemes in Central-Eastern Europe and Middle-East

    Delayed payment schemes in Central-Eastern Europe and Middle-East oleh Ildikó Ádám, Marcelien Callenbach, Bertalan Németh, Rick A. Vreman, Rick A. Vreman, Johan Pontén, Tea Strbad, Dalia Dawoud, Alexander Kostyuk, Ahmed Seyam, László Nagy, Wim G. Goettsch, Wim G. Goettsch, Zoltán Kaló, Zoltán Kaló

    Diterbitkan 2022-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  18. 18
    Potential Barriers of Patient Involvement in Health Technology Assessment in Central and Eastern European Countries

    Potential Barriers of Patient Involvement in Health Technology Assessment in Central and Eastern European Countries oleh Maria Dimitrova, Ivett Jakab, Zornitsa Mitkova, Maria Kamusheva, Konstantin Tachkov, Bertalan Nemeth, Antal Zemplenyi, Antal Zemplenyi, Dalia Dawoud, Dalia Dawoud, Diana M. J. Delnoij, Diana M. J. Delnoij, François Houýez, Zoltan Kalo, Zoltan Kalo

    Diterbitkan 2022-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  19. 19
    Implementation of Health Technology Assessment in the Middle East and North Africa: Comparison Between the Current and Preferred Status

    Implementation of Health Technology Assessment in the Middle East and North Africa: Comparison Between the Current and Preferred Status oleh Ahmad Fasseeh, Ahmad Fasseeh, Rita Karam, Mouna Jameleddine, Mohsen George, Finn Børlum Kristensen, Abeer A. Al-Rabayah, Abdulaziz H. Alsaggabi, Maha El Rabbat, Maha El Rabbat, Maryam S. Alowayesh, Julia Chamova, Adham Ismail, Sherif Abaza, Zoltán Kaló, Zoltán Kaló

    Diterbitkan 2020-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  20. 20
    Development of a core evaluation framework of value-added medicines: report 2 on pharmaceutical policy perspectives

    Development of a core evaluation framework of value-added medicines: report 2 on pharmaceutical policy perspectives oleh Zoltán Kaló, Zsuzsanna Ida Petykó, Frank-Ulrich Fricke, Nikos Maniadakis, Tomáš Tesař, Kateřina Podrazilová, Jaime Espin, András Inotai

    Diterbitkan 2021-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: